Explore groundbreaking studies, reviews, and discoveries in ubiquitination pathways
Explore the groundbreaking pre-clinical research on CB-5083, a novel p97 inhibitor showing significant promise in treating multiple myeloma by targeting cancer cells' protein disposal systems.